Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Remdesivir bij COVID-19: eindresultaten van de WHO Solidarity-studie
aug 2022 | Pneumonie, Virale infecties